Acute hepatitis B (1) may have epidemiological history or blood transfusion, blood products or other drug injection history; (2) clinical manifestations of acute hepatitis; (3) liver function tests, In particular ALT, AST increased, with or without increased bilirubin; (4) acute phase: HBsAg positive, can be accompanied by a short HBeAg and HBV-DNA or DNAP positive high-titer anti-HBc.IgM positive, positive anti-HBc.IgG low titer; (5) recovery: HBsAg and anti-HBc.IgM low titers (down), and finally to overcast. The titer of anti-HBc.IgG rise in anti-HBs - positive.
Chronic hepatitis B (1) may have a history of acute hepatitis (often not obvious), (2) clinical performance and abnormal liver function over six months or more (3) continued HBsAg positive more than six months, with the total anti-HBc antibody and the IgG antibody positive activities such as the period for the anti-HBc.IgM be a medium, and low titer positive (4) HBeAg and HBV-DNA and DNAP positive or negative and the three former anti-HBe positive (5) for liver biopsy to further clarify the chronic persistent hepatitis, chronic active hepatitis or chronic lobular hepatitis. Asymptomatic HBsAg carriers without any clinical signs and symptoms of hepatitis, no abnormal liver function, sustained HBsAg positive for more than 6 months.
No comments:
Post a Comment